SecBot SecBot
NT 10-Q ·Filed Nov 17, 2026

BTAIQ

BioXcel Therapeutics, Inc.
BEARISH
Impact 7/10
Processed15m ago SEC0001104659-26-129119
Late quarterly filing (signals accounting problems)

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
NT 10-Q Filing (Primary)0001104659-26-129119
Document: 0001104659-26-129119-index-headers.html0001104659-26-129119
Document: 0001104659-26-129119-index.html0001104659-26-129119
Document: 0001104659-26-129119.txt0001104659-26-129119

Track record

3 reports on BTAIQ

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 17, 2026today NT 10-Q Bearish 7/10 Viewing Entry $0.0120 Now $0.008000 +33.33% settles Nov 25
  2. Oct 30, 202618d ago 8-K Bearish 7/10 Entry $0.0130 to $0.008000 Now $0.008000 +38.46% ▲ +38.46% +38.54% vs SPY
  3. May 22, 202625w ago Insider Cluster Bearish 5/10 Entry $1.22 to $1.19 Now $0.008000 +99.34% ▲ +2.46% +3.67% vs SPY
Showing 3 of 3

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026

Fresh BTAIQ Intelligence

Analysis is for subscribers only.

Subscribe for Full Access